review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jonathan Prousky | |
P2860 | cites work | Alcoholic drinks: Important triggers for asthma | Q57297524 |
Nebulized Glutathione Induces Bronchoconstriction in Patients with Mild Asthma | Q58317036 | ||
Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts | Q69665738 | ||
Normal alveolar epithelial lining fluid contains high levels of glutathione | Q70192137 | ||
Immunocytochemical evidence for the expression of GST1, GST2, and GST3 gene loci for glutathione S-transferase in human lung | Q70374775 | ||
Selective modification of glutathione metabolism | Q71695892 | ||
Protective role of glutathione on alpha 1 proteinase inhibitor inactivation by the myeloperoxidase system. Hypothetic study for therapeutic strategy in the management of smokers' emphysema | Q72166256 | ||
Glutathione in the upper respiratory tract | Q72548010 | ||
The use of nebulized glutathione in the treatment of emphysema: a case report | Q73135489 | ||
Pulmonary glutathione levels in acute episodes of Farmer's lung | Q73893418 | ||
Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis | Q78010335 | ||
Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity: central role of N-methyl-D-aspartate receptors in the sensitivity mechanism | Q24530101 | ||
Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge | Q24812250 | ||
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies | Q25256652 | ||
The systemic availability of oral glutathione | Q28184603 | ||
Immunohistochemical localization of glutathione S-transferases in human lung | Q28256397 | ||
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol | Q33602209 | ||
Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. | Q33796510 | ||
Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis | Q33958399 | ||
Oxidative stress and regulation of glutathione in lung inflammation | Q34058330 | ||
Adverse reactions to sulfites | Q34300111 | ||
A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis | Q34385042 | ||
Results of a controlled clinical trial of glutathione in cases of hepatic cirrhosis | Q35002621 | ||
Role of sulfite additives in wine induced asthma: single dose and cumulative dose studies | Q35534176 | ||
Properties of highly purified leukotriene C4 synthase of guinea pig lung | Q35586687 | ||
Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment | Q36287550 | ||
Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review | Q36444282 | ||
Environmental agents altering lung biochemistry | Q39618867 | ||
γ-Glutamyl transpeptidase: catalytic, structural and functional aspects | Q40085819 | ||
Glutathione metabolism as a determinant of therapeutic efficacy: a review | Q40184201 | ||
Glutathione in health and disease: pharmacotherapeutic issues | Q41009883 | ||
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy | Q41300350 | ||
Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro | Q41496031 | ||
Lung disease due to alpha 1-antitrypsin deficiency. | Q41638455 | ||
Suspicion on sulfites | Q41905169 | ||
Management of chronic otitis media with effusion: the role of glutathione | Q43745684 | ||
Can't lung cancer patients detoxify procarcinogens? | Q43951220 | ||
Therapy of lung diseases with anti-oxidants | Q44085698 | ||
Expression of drug resistance gene products during progression of lung carcinomas. | Q44175925 | ||
Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis | Q44268014 | ||
Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis | Q44730528 | ||
Mucosal symptoms elicited by fragrance products in a population-based sample in relation to atopy and bronchial hyper-reactivity. | Q45222911 | ||
Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs | Q46617956 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 27-35 | |
P577 | publication date | 2008-03-01 | |
P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
P1476 | title | The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione | |
P478 | volume | 5 |
Q28382991 | A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins |
Q35103370 | An Angiotensin I converting enzyme polymorphism is associated with clinical phenotype when using differentiation-syndrome to categorize korean bronchial asthma patients |
Q23909571 | Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure |
Q34211581 | Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers |
Q37372896 | Glutathione dysregulation and the etiology and progression of human diseases. |
Q91981746 | Impact of Supplementary Amino Acids, Micronutrients, and Overall Diet on Glutathione Homeostasis |
Q42006733 | Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense |
Q38135388 | Regulation of ion transport by oxidants |
Q36836501 | Safety survey of intranasal glutathione. |
Q55441110 | Vitamin C in Cancer: A Metabolomics Perspective. |
Search more.